Edesa Biotech, Inc. — Director's Dealing 2016

Dec 21, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Stellar Biotechnologies, Inc. (SBOT)
CIK: 0001540159
Period of Report: 2016-12-20

Reporting Person: MORSE DANIEL E. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-12-20	Share Option (Right to Buy)	$2.03	A	2500	Acquired	2023-12-20	Common Shares (2500)	Direct

Footnotes

F1: Option grant under the 2013 Fixed Share Option Plan, which shall vest as to one-third immediately, as to one-third on December 20, 2017 and as to the remaining one-third on June 20, 2018.